Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Nicardipine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

32 API Suppliers, 15 USDMF, 1 JDMF, 2 EU WC, 2 KDMF, 8 NDC API, 20 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

64 FDF Dossiers, 45 FDA Orange Book, 6 Europe, 1 South Africa, 12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAVENOUS - 20MG/200ML (0.1MG/ML), INJECTABLE;INJECTION - 25MG/10ML (2.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAVENOUS - 40MG/200ML (0.2MG/ML)

RELATED EXCIPIENT COMPANIES

2 Evonik, 1 Rochem International Inc, 6 SPI Pharma, 8 DKSH, 3 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 2 Actylis, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 3 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 6 Kerry, 3 Lonza Capsugel, 7 Microlex e.U, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 28 Roquette, 2 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 2 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

40 Fillers, Diluents & Binders, 28 Coating Systems & Additives, 16 Direct Compression, 16 Thickeners and Stabilizers, 14 Taste Masking, 14 Controlled & Modified Release, 13 Film Formers & Plasticizers, 12 Lubricants & Glidants, 11 Granulation, 10 Co-Processed Excipients, 8 Empty Capsules, 7 Disintegrants & Superdisintegrants, 7 Chewable & Orodispersible Aids, 7 Parenteral, 5 Solubilizers, 4 Topical, 4 Emulsifying Agents, 3 Coloring Agents, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents, 1 Rheology Modifiers, 1 Soft Gelatin

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 18 News #PharmaBuzz

GLOBAL SALES INFORMATION

7 Regulatory FDF Prices

7 Regulatory FDF Prices

MARKET PLACE

17 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

22 US Patents, 2 US Exclusivities, 5 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 4 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/03/2025	ChemWerth Inc	U.S.A	CHEMWERTH INC	19552	NICARDIPINE HYDROCHLORIDE, NON-STERILE, BULK DRUG SUBSTANCE	2006-06-26	Active	II	N/A
28/03/2025	Metrochem API Private Limited	India	METROCHEM API PRIVATE LTD	40235	NICARDIPINE HYDROCHLORIDE USP	2024-08-31	Active	II	Complete	2025-03-04	2025-02-14

Nicardipine

Nicardipine

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

32 API Suppliers

15 USDMF

1 JDMF

2 EU WC

2 KDMF

8 NDC API

20 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

64 FDF Dossiers

45 FDA Orange Book

6 Europe

1 South Africa

12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAVENOUS - 20MG/200ML (0.1MG/ML)

INJECTABLE;INJECTION - 25MG/10ML (2.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INTRAVENOUS - 40MG/200ML (0.2MG/ML)

RELATED EXCIPIENT COMPANIES

2 Evonik

1 Rochem International Inc

6 SPI Pharma

8 DKSH

3 Faran Shimi Pharmaceutical

4 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

4 ACG Worldwide

2 Actylis

1 Alcedo Pharmachem

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

11 BASF

3 Corel Pharma Chem

2 DFE Pharma

1 Finar

6 Gangwal Chemicals

5 Ideal Cures Pvt Ltd

2 Ingredion Pharma Solutions

6 Kerry

3 Lonza Capsugel

7 Microlex e.U

1 Pharmatrans-Sanaq

3 Pluviaendo

2 Prachin Chemical

1 Qualicaps

28 Roquette

2 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

8 Sigachi Industries

2 Valens Pharmachem

2 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

40 Fillers, Diluents & Binders

28 Coating Systems & Additives

16 Direct Compression

16 Thickeners and Stabilizers

14 Taste Masking

14 Controlled & Modified Release

13 Film Formers & Plasticizers

12 Lubricants & Glidants

11 Granulation

10 Co-Processed Excipients

8 Empty Capsules

7 Disintegrants & Superdisintegrants

7 Chewable & Orodispersible Aids

7 Parenteral

5 Solubilizers

4 Topical

INJECTABLE;INJECTION - 25MG/10ML (2.5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons